Publication | Open Access
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registry
37
Citations
4
References
2021
Year
Most AD patients continued systemic treatments during COVID pandemic and lockdown period, without high impact on disease control, particularly dupilumab-treated patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1